CART ITEM (0)
report cover

Acute Myeloid Leukemia (AML) Therapeutics Market, Global Outlook and Forecast 2023-2029

  • 20 May 2023
  • ICT & Media
  • 67 Pages
  • Report code : 24WT-7693157
sample cover   Download Free PDF sample

Acute Myeloid Leukemia Therapeutics and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 Acute Myeloid Leukemia (AML) Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Myeloid Leukemia (AML) Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Myeloid Leukemia (AML) Therapeutics Overall Market Size
2.1 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size: 2022 VS 2029
2.2 Global Acute Myeloid Leukemia (AML) Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Acute Myeloid Leukemia (AML) Therapeutics Players in Global Market
3.2 Top Global Acute Myeloid Leukemia (AML) Therapeutics Companies Ranked by Revenue
3.3 Global Acute Myeloid Leukemia (AML) Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Acute Myeloid Leukemia (AML) Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Acute Myeloid Leukemia (AML) Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Acute Myeloid Leukemia (AML) Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Acute Myeloid Leukemia (AML) Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia (AML) Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Myeloid Leukemia (AML) Therapeutics Market Size Markets, 2022 & 2029
4.1.2 Chemotherapy
4.1.3 Radiation therapy
4.1.4 Stem Cell Transplant
4.1.5 Targeted Therapy
4.1.6 Others
4.2 By Type - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2018-2029
6.3.2 US Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.3.3 Canada Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.3.4 Mexico Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2018-2029
6.4.2 Germany Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.4.3 France Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.4.4 U.K. Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.4.5 Italy Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.4.6 Russia Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.4.8 Benelux Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2018-2029
6.5.2 China Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.5.3 Japan Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.5.4 South Korea Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.5.6 India Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2018-2029
6.6.2 Brazil Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.6.3 Argentina Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2018-2029
6.7.2 Turkey Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.7.3 Israel Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
6.7.5 UAE Acute Myeloid Leukemia (AML) Therapeutics Market Size, 2018-2029
7 Acute Myeloid Leukemia (AML) Therapeutics Companies Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Major Product Offerings
7.1.4 Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Bristol-Myers Squibb Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Acute Myeloid Leukemia (AML) Therapeutics Major Product Offerings
7.2.4 Novartis Acute Myeloid Leukemia (AML) Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Acute Myeloid Leukemia (AML) Therapeutics Major Product Offerings
7.3.4 Roche Acute Myeloid Leukemia (AML) Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Genmab
7.4.1 Genmab Company Summary
7.4.2 Genmab Business Overview
7.4.3 Genmab Acute Myeloid Leukemia (AML) Therapeutics Major Product Offerings
7.4.4 Genmab Acute Myeloid Leukemia (AML) Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Genmab Key News & Latest Developments
7.5 GlaxoSmithKline Pharmaceuticals
7.5.1 GlaxoSmithKline Pharmaceuticals Company Summary
7.5.2 GlaxoSmithKline Pharmaceuticals Business Overview
7.5.3 GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Major Product Offerings
7.5.4 GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Revenue in Global Market (2018-2023)
7.5.5 GlaxoSmithKline Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Acute Myeloid Leukemia (AML) Therapeutics Market Opportunities & Trends in Global Market
Table 2. Acute Myeloid Leukemia (AML) Therapeutics Market Drivers in Global Market
Table 3. Acute Myeloid Leukemia (AML) Therapeutics Market Restraints in Global Market
Table 4. Key Players of Acute Myeloid Leukemia (AML) Therapeutics in Global Market
Table 5. Top Acute Myeloid Leukemia (AML) Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Acute Myeloid Leukemia (AML) Therapeutics Product Type
Table 9. List of Global Tier 1 Acute Myeloid Leukemia (AML) Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Myeloid Leukemia (AML) Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Acute Myeloid Leukemia (AML) Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Acute Myeloid Leukemia (AML) Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Acute Myeloid Leukemia (AML) Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Acute Myeloid Leukemia (AML) Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Bristol-Myers Squibb Company Summary
Table 31. Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Product Offerings
Table 32. Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Bristol-Myers Squibb Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Acute Myeloid Leukemia (AML) Therapeutics Product Offerings
Table 36. Novartis Acute Myeloid Leukemia (AML) Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Acute Myeloid Leukemia (AML) Therapeutics Product Offerings
Table 40. Roche Acute Myeloid Leukemia (AML) Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Key News & Latest Developments
Table 42. Genmab Company Summary
Table 43. Genmab Acute Myeloid Leukemia (AML) Therapeutics Product Offerings
Table 44. Genmab Acute Myeloid Leukemia (AML) Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Genmab Key News & Latest Developments
Table 46. GlaxoSmithKline Pharmaceuticals Company Summary
Table 47. GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Product Offerings
Table 48. GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. GlaxoSmithKline Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Acute Myeloid Leukemia (AML) Therapeutics Segment by Type in 2022
Figure 2. Acute Myeloid Leukemia (AML) Therapeutics Segment by Application in 2022
Figure 3. Global Acute Myeloid Leukemia (AML) Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acute Myeloid Leukemia (AML) Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Acute Myeloid Leukemia (AML) Therapeutics Revenue in 2022
Figure 8. By Type - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Acute Myeloid Leukemia (AML) Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Acute Myeloid Leukemia (AML) Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Bristol-Myers Squibb Acute Myeloid Leukemia (AML) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Acute Myeloid Leukemia (AML) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Acute Myeloid Leukemia (AML) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Genmab Acute Myeloid Leukemia (AML) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GlaxoSmithKline Pharmaceuticals Acute Myeloid Leukemia (AML) Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

User License

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

Delivery Time

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

Payment Options

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

Report Delivery

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SIMILAR REPORTS


SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
  • Toshiba
  • yamaha
  • nest
  • hp
  • campbell
  • Deloitte
  • Panasonic
  • sit-group
  • Spirax-Sarco
  • Chevron
  • Zeiss
  • showa denko
  • rolandberger
  • valens
  • harris1
  • mckinsey
  • perkinscoie
  • Saviola
  • gelita
  • Allocatesoft
  • siva-group
  • Chevron
  • Zeiss
  • showa denko
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Acute Myeloid Leukemia Therapeutics and Forecast Market

Leave This Empty: